Actively Recruiting
Treatment of Upper Gastrointestinal Symptoms Using Hypnotherapy Sessions
Led by Mayo Clinic · Updated on 2026-03-04
100
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research is to evaluate if hypnotherapy delivered digitally will help your GI symptoms.
CONDITIONS
Official Title
Treatment of Upper Gastrointestinal Symptoms Using Hypnotherapy Sessions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients meeting criteria for at least one upper GI disorder including functional dyspepsia, nausea/vomiting disorders, or functional abdominal bloating
- Inclusion of lower GI disorders like IBS if primary symptoms are upper GI or bloating/distension
- Negative 4-hour solid food gastric emptying test previously or normal C13 breath test at screening
- Patients with disaccharide intolerances allowed if dietary restrictions are maintained
- Patients using cannabinoid-based substances allowed if no dose changes during study
- Proficiency in English for understanding study content
- Reliable access to digital devices for content delivery and questionnaires over study and follow-up period
You will not qualify if you...
- Current diagnosis of small intestinal bacterial overgrowth, gastroparesis, rumination syndrome, chronic intestinal pseudo-obstruction, advanced connective tissue diseases (e.g. scleroderma), or uncontrolled inflammatory bowel disease
- Untreated Helicobacter pylori infection
- Untreated pelvic floor dysfunction in patients with predominant bloating and constipation
- History of cognitive delay, traumatic brain injury with lasting deficits, stroke with cognitive impairment, or dementia
- Significant psychiatric illness with psychosis or severe untreated major depression with suicidal thoughts
- Substance abuse disorders or drug addiction
- Unlikely to comply with or benefit from psychotherapy-based interventions as judged by medical provider
- Pregnancy
- Structural or metabolic diseases that could interfere with study results
- Medication doses should be stable and not changed during study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
T
Taylor Hines
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here